Rescue of neurons from undergoing hallmark tau-induced Alzheimer's disease cell pathologies by the antimitotic drug paclitaxel.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Neurobiology of Disease

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.nbd.2011.03.008PMID 21406229
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Paclitaxel induces axonal microtubules polar reconfiguration and impaired organelle transport: implications for the pathogenesis of paclitaxel-induced polyneuropathy

  2010cited by this paper
• Hallmark cellular pathology of Alzheimer’s disease induced by mutant human tau expression in cultured Aplysia neurons

  2010cited by this paper
• Soluble hyper-phosphorylated tau causes microtubule breakdown and functionally compromises normal tau in vivo

  2010cited by this paper
• Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.

  2010cited by this paper
• Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.

  2010cited by this paper
• Disruption of neuronal function by soluble hyperphosphorylated tau in a Drosophila model of tauopathy.

  2010cited by this paper
• Paclitaxel accelerates spontaneous calcium oscillations in cardiomyocytes by interacting with NCS-1 and the InsP3R.

  2010cited by this paper
• Epothilone D Improves Microtubule Density, Axonal Integrity, and Cognition in a Transgenic Mouse Model of Tauopathy

  2010cited by this paper
• Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies

  2009cited by this paper
• Local calcium-dependent mechanisms determine whether a cut axonal end assembles a retarded endbulb or competent growth cone.

  2009cited by this paper
• Dynamic microtubules regulate dendritic spine morphology and synaptic plasticity.

  2009cited by this paper
• Effects of Cell Cycle Inhibitors on Tau Phosphorylation in N2aTau3R Cells

  2008cited by this paper
• Development of practical syntheses of the marine anticancer agents discodermolide and dictyostatin.

  2008cited by this paper
• Tubulin-interactive natural products as anticancer agents.

  2008cited by this paper
• The Last Tangle of Tau

  2008cited by this paper
• Tau‐Induced Traffic Jams Reflect Organelles Accumulation at Points of Microtubule Polar Mismatching

  2008cited by this paper
• Epothilones as lead structures for the synthesis-based discovery of new chemotypes for microtubule stabilization.

  2008cited by this paper
• Taxol Crystals Can Masquerade as Stabilized Microtubules

  2008cited by this paper
• Microtubule plus-end tracking proteins in differentiated mammalian cells.

  2008cited by this paper
• Local self‐assembly mechanisms underlie the differential transformation of the proximal and distal cut axonal ends into functional and aberrant growth cones

  2008influential reference
• Neurodegenerative lysosomal disorders: A continuum from development to late age

  2008cited by this paper
• How do microtubule-targeted drugs work? An overview.

  2007cited by this paper
• Frontotemporal Dementia with Tau Pathology

  2007cited by this paper
• Formation of microtubule-based traps controls the sorting and concentration of vesicles to restricted sites of regenerating neurons after axotomy

  2007cited by this paper
• Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

  2007cited by this paper
• Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpain-mediated neuronal calcium sensor-1 degradation

  2007cited by this paper
• Microtubule-stabilizing agent prevents protein accumulation-induced loss of synaptic markers.

  2007cited by this paper
• A microtubule-based, dynein-dependent force induces local cell protrusions: Implications for neurite initiation

  2007cited by this paper
• Quantitative evaluation of the mode of microtubule transport in Xenopus neurons.

  2006cited by this paper
• Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination.

  2006cited by this paper
• Tau Protects Microtubules in the Axon from Severing by Katanin

  2006cited by this paper
• Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism

  2006cited by this paper
• Microtubules cut and run.

  2005cited by this paper
• Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy model.

  2005cited by this paper
• β-Amyloid-Induced Neurodegeneration and Protection by Structurally Diverse Microtubule-Stabilizing Agents

  2005cited by this paper
• Neuronal microtubules: when the MAP is the roadblock.

  2005cited by this paper
• Linking axonal degeneration to microtubule remodeling by Spastin-mediated microtubule severing

  2005cited by this paper
• Mitochondrial K(ATP) channels in respiratory neurons and their role in the hypoxic facilitation of rhythmic activity.

  2005cited by this paper
• Axonopathy and Transport Deficits Early in the Pathogenesis of Alzheimer's Disease

  2005cited by this paper
• Quantitative analysis of microtubule transport in growing nerve processes.

  2004cited by this paper
• Neurodegeneration and defective neurotransmission in a Caenorhabditis elegans model of tauopathy

  2003cited by this paper
• Effective expression of the green fluorescent fusion proteins in cultured Aplysia neurons.

  2003cited by this paper
• Visualization of Microtubule Growth in Cultured Neurons via the Use of EB3-GFP (End-Binding Protein 3-Green Fluorescent Protein)

  2003cited by this paper
• Critical calpain‐dependent ultrastructural alterations underlie the transformation of an axonal segment into a growth cone after axotomy of cultured Aplysia neurons

  2003cited by this paper
• Repeat motifs of tau bind to the insides of microtubules in the absence of taxol

  2003cited by this paper
• Tau neurofibrillary pathology and microtubule stability

  2002cited by this paper
• Paclitaxel Affects Cytosolic Calcium Signals by Opening the Mitochondrial Permeability Transition Pore*

  2002cited by this paper
• Single‐molecule investigation of the interference between kinesin, tau and MAP2c

  2002cited by this paper
• Fast axonal transport misregulation and Alzheimer’s Disease

  2002cited by this paper
• Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress

  2002cited by this paper
• Katanin-mediated microtubule severing can be regulated by multiple mechanisms.

  2002cited by this paper
• Neurodegenerative tauopathies.

  2001cited by this paper
• Tauopathy in Drosophila: Neurodegeneration Without Neurofibrillary Tangles

  2001cited by this paper
• Cellular Samurai: katanin and the severing of microtubules.

  2000cited by this paper
• Nuclear Factor-κB/IκB Signaling Pathway May Contribute to the Mediation of Paclitaxel-induced Apoptosis in Solid Tumor Cells

  2000cited by this paper
• Nuclear factor-kappaB/IkappaB signaling pathway may contribute to the mediation of paclitaxel-induced apoptosis in solid tumor cells.

  2000cited by this paper
• EB3, a novel member of the EB1 family preferentially expressed in the central nervous system, binds to a CNS-specific APC homologue

  2000cited by this paper
• How Taxol stabilises microtubule structure.

  1999cited by this paper
• Molecular effects of paclitaxel: Myths and reality (a critical review)

  1999cited by this paper
• An Essential Role for Katanin in Severing Microtubules in the Neuron

  1999cited by this paper
• CLIP-170 highlights growing microtubule ends in vivo.

  1999cited by this paper
• Protection against beta-amyloid toxicity in primary neurons by paclitaxel (Taxol).

  1998cited by this paper
• Similarity Between the Sequences of Taxol-Selected Peptides and the Disordered Loop of the Anti-Apoptotic Protein, BCL-2

  1998cited by this paper
• Tau in Alzheimer's disease.

  1998cited by this paper
• Photosensitisation properties of mitochondrially localised green fluorescent protein.

  1998cited by this paper
• Protection Against β‐Amyloid Toxicity in Primary Neurons by Paclitaxel (Taxol)

  1998cited by this paper
• Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

  1997cited by this paper
• Use of Aplysia neurons for the study of cellular alterations and the resealing of transected axons in vitro.

  1996cited by this paper
• Interaction of tau with the neural plasma membrane mediated by tau's amino-terminal projection domain

  1995cited by this paper
• Microtubule stabilizing drugs for the treatment of Alzheimer's disease.

  1994influential reference
• Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding.

  1993cited by this paper
• Modulation of the dynamic instability of tubulin assembly by the microtubule-associated protein tau.

  1992cited by this paper
• Neurite regeneration by Aplysia neurons in dissociated cell culture: modulation by Aplysia hemolymph and the presence of the initial axonal segment

  1983cited by this paper
• Microtubule arrays in taxol-treated mouse dorsal root ganglion-spinal cord cultures.

  1981cited by this paper
• Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores.

  1981cited by this paper

• Mechanical stimulation prevents impairment of axon growth and overcompensates microtubule destabilization in cellular models of Alzheimer’s disease and related Tau pathologies

  2025cites this paper
• Neuroprotective role of Hippo signaling by microtubule stability control in Caenorhabditis elegans

  2025cites this paper
• Anti-herpetic tau preserves neurons via the cGAS-STING-TBK1 pathway in Alzheimer's disease.

  2024cites this paper
• Host response to Aplysia Abyssovirus 1 in nervous system and gill.

  2024cites this paper
• Role of 14-3-3 protein family in the pathobiology of EBV in immortalized B cells and Alzheimer’s disease

  2024cites this paper
• Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed Drugs

  2024cites this paper
• Recent Advancement in Therapeutic Strategies for Alzheimer's Disease: Insights from Clinical Trials.

  2023cites this paper
• Foresee novel targets for Alzheimer's disease by investigating repurposed drugs.

  2022cites this paper
• Microtubules as Regulators of Neural Network Shape and Function: Focus on Excitability, Plasticity and Memory

  2022cites this paper
• Aplysia Neurons as a Model of Alzheimer’s Disease: Shared Genes and Differential Expression

  2021cites this paper
• Paclitaxel and its derivative facilitate the transmission of plasmid-mediated antibiotic resistance genes through conjugative transfer.

  2021cites this paper
• Therapeutic Targeting of Repurposed Anticancer Drugs in Alzheimer’s Disease: Using the Multiomics Approach

  2021cites this paper
• OMICS-BASED EXPLORATION AND FUNCTIONAL VALIDATION OF NEUROTROPHIC FACTORS AND HISTAMINE AS THERAPEUTIC TARGETS IN ALS.

  2020cites this paper
• Investigation of low dose cabazitaxel potential as microtubule stabilizer in experimental model of Alzheimer's disease: Restoring neuronal cytoskeleton.

  2020cites this paper
• Microtubule-targeting agents and neurodegeneration.

  2020cites this paper
• “Amyloid‐beta accumulation cycle” as a prevention and/or therapy target for Alzheimer's disease

  2020cites this paper
• Regulation of neuronal microtubule dynamics by tau: Implications for tauopathies.

  2019cites this paper
• Potential Neuroprotective Peptide Emerged from Dual Neurotherapeutic Targets: A Fusion Approach for the Development of Anti-Alzheimer's Lead.

  2019cites this paper
• Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings

  2019cites this paper
• Viral Induced Oxidative and Inflammatory Response in Alzheimer’s Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach

  2019cites this paper
• Therapeutic Strategies for the Treatment of Alzheimer ’ s Disease-Recent Advances and Future Perspective Chapter 1 Alzheimer ’ s Disease & Treatment

  2018cites this paper
• Optical trapping and single molecule measurement technologies for the investigation of biomolecular forces and motion

  2018cites this paper
• Crafting of Neuroprotective Octapeptide from Taxol-Binding Pocket of β-Tubulin.

  2017cites this paper
• Selection and Prioritization of Candidate Drug Targets for Amyotrophic Lateral Sclerosis Through a Meta-Analysis Approach

  2017influential citation
• Dysregulation of Microtubule Stability Impairs Morphofunctional Connectivity in Primary Neuronal Networks

  2017cites this paper
• Microtubule density and landing rate as parameters to analyze tau protein in the MT-kinesin "gliding" assay

  2017cites this paper
• Tau-Centric Therapies for Treating Alzheimer’s Disease

  2017cites this paper
• Neurotoxic Mechanisms of the Chemotherapeutic Paclitaxel

  2016cites this paper
• Microtubule Dynamics in Neuronal Development, Plasticity, and Neurodegeneration.

  2016cites this paper
• Current Research Therapeutic Strategies for Alzheimer's Disease Treatment

  2016cites this paper
• A Case for Microtubule Vulnerability in Amyotrophic Lateral Sclerosis: Altered Dynamics During Disease

  2016cites this paper
• Tau and spectraplakins promote synapse formation and maintenance through Jun kinase and neuronal trafficking

  2016cites this paper
• Do Cancer Drugs Counteract Neurodegeneration? Repurposing for Alzheimer’s Disease

  2016cites this paper
• Broader implications: Biological and clinical significance of microtubule acetylation

  2015cites this paper
• Selection of Potential Pharmacological Targets in ALS Based on Whole- Genome Expression Profiling.

  2015cites this paper
• Cancer based pharmacogenomics network supported with scientific evidences: from the view of drug repurposing

  2015cites this paper
• The role of high-fat diet in an APP/PS1 model of familial Alzheimer disease = Efecto de una dieta rica en grasas en ratones APP/PS1, modelo familiar de la enfermedad de Alzheimer

  2015cites this paper
• Transcriptional analysis reveals distinct subtypes in amyotrophic lateral sclerosis: implications for personalized therapy.

  2015cites this paper
• Microtubule Regulation in Cystic Fibrosis Pathophysiology

  2015cites this paper
• Trends and Applications in Knowledge Discovery and Data Mining

  2014cites this paper
• The Drug Development Based on Pathogenetic Research in Alzheimer’s Disease

  2014cites this paper
• Microtubule-targeting agents: a therapeutic strategy in neurodegenerative diseases

  2014cites this paper
• Advances in therapeutics for neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species.

  2014cites this paper
• The paradox of paclitaxel neurotoxicity: Mechanisms and unanswered questions.

  2014cites this paper
• Recent progress with microtubule stabilizers: new compounds, binding modes and cellular activities.

  2014cites this paper
• Rescue of tau-induced synaptic transmission pathology by paclitaxel

  2014cites this paper
• Cancer Based Pharmacogenomics Network for Drug Repurposing

  2014cites this paper
• From an Axon into a Growth Cone After Axotomy: A Model for Cytoskeletal Dynamics

  2013cites this paper
• Beyond taxol: microtubule-based treatment of disease and injury of the nervous system.

  2013cites this paper
• Discovering new treatments for Alzheimer's disease by repurposing approved medications.

  2013cites this paper
• Notch signalling in adult neurons: a potential target for microtubule stabilization

  2013cites this paper
• Taxol Producing Fungi

  2013cites this paper
• Excitotoxin-induced caspase-3 activation and microtubule disintegration in axons is inhibited by taxol

  2013cites this paper
• Microtubule stabilization by peloruside A and paclitaxel rescues degenerating neurons from okadaic acid‐induced tau phosphorylation

  2012cites this paper
• Hyperdynamic Microtubules, Cognitive Deficits, and Pathology Are Improved in Tau Transgenic Mice with Low Doses of the Microtubule-Stabilizing Agent BMS-241027

  2012influential citation
• Proteinopathies, neurodegenerative disorders with protein aggregation-based pathology

  2012cites this paper
• The ADNP Derived Peptide, NAP Modulates the Tubulin Pool: Implication for Neurotrophic and Neuroprotective Activities

  2012cites this paper
• Microtubule stabilizing agents as potential treatment for Alzheimer's disease and related neurodegenerative tauopathies.

  2012cites this paper